Home       About             Help      

Select plot or tool >
Pheno measurements correlated to your selected measurements

Pearson correlation p value
must be p ≤


Download all
At least
strains
in common
are required
Include:
females and males
females only
males only

Order by


More info on correlations


Your selected measurement:
brain — cerebral cortex — biochemical analytes         reverse ELISA  
Wiltshire3
PAQR8_index   progestin and adipoQ receptor family member VIII (PAQR8), change index   fluoxetine 30 strains   age 10-11wks
  Inbred
 

Download this list as a tab-delimited file
 
Correlated measurement from anywhere in MPD
(organized by category)
Sex Pearson
r
p value
on r
Spearman
rs
# strains
in
common
Click
for
scatterplot
Log-
improved
Pearson
blood – clinical chemistry – electrolytes
Yuan3   Phos_M06  
phosphorous (serum P) (age 6mo)
male 0.66 p = 0.0050 0.76 16 Plot  
Yuan3   Cl_M18  
chloride (serum Cl) (age 18mo)
male 0.58 p = 0.0087 0.53 19 Plot  
blood – clinical chemistry – enzymes
Rusyn5   ALT_hfe  
serum alanine aminotransferase (ALT) (high-fat diet and ethanol 4wks)
male –0.85 p = 0.0077 –0.55 8 Plot  
blood – clinical chemistry – proteins
Peters1   Fib  
fibrinogen
male –0.51 p = 0.0079 –0.56 26 Plot  
blood – hematology – cell counts – WBC – neutrophils
Peters4   NEUT_M06  
neutrophil count (NEUT; units per volume x 103) (age 6mo)
male –0.58 p = 0.0069 –0.22 20 Plot  
blood – lipids – cholesterol – HDL
Yuan3   HDL_M12  
HDL cholesterol (plasma HDL) (age 12mo)
male –0.55 p = 0.0091 –0.38 21 Plot  
blood – lipids – cholesterol – total
Shockley1   CHOL  
total cholesterol (serum CHOL, 5h fast)
male –0.82 p = 0.0064 –0.77 9 Plot  
body weight size and growth – body mass index (BMI)
Ackert1   BMI_M20  
body mass index (BMI) (age 20mo)
male –0.62 p = 0.0086 –0.24 17 Plot  
body weight size and growth – body weight
Maurer1   bwchg_iso1  
fold change in body weight over testing period (isoproterenol 1mg/kg)
male –0.63 p = 0.0031 –0.39 20 Plot  
Maurer1   bwchg_at  
fold change in body weight over testing period (atenolol 10mg/kg)
male –0.58 p = 0.0073 –0.33 20 Plot  
bone – mineral density and content
Naggert1   BMD_fat8  
bone mineral density (BMD) (high-fat diet 8wks)
male –0.59 p = 0.0031 –0.51 23 Plot  
brain – cerebral cortex
Wiltshire3   SLC6A2_index  
sodium-dependent noradrenaline transporter (SLC6A2 formerly NET), change index (fluoxetine )
male 0.81 p < 0.0001 0.66 30 Plot  
Wiltshire3   GHRL_index  
ghrelin (GHRL), change index (fluoxetine )
male 0.77 p < 0.0001 0.67 30 Plot  
Wiltshire3   PAQR8_fluox  
progestin and adipoQ receptor family member VIII (PAQR8), relative fluorescence intensity (fluoxetine )
male 0.74 p < 0.0001 0.69 30 Plot  
Wiltshire3   PAQR8_cont  
progestin and adipoQ receptor family member VIII (PAQR8), relative fluorescence intensity
male –0.71 p < 0.0001 –0.67 30 Plot  
Wiltshire3   CREB1_index  
cyclic AMP-responsive element-binding protein 1 (CREB1 formerly CREB), change index (fluoxetine )
male 0.71 p < 0.0001 0.60 30 Plot  
Wiltshire3   FOS_index  
proto-oncogene c-Fos (FOS formerly c-fos), change index (fluoxetine )
male 0.69 p < 0.0001 0.54 30 Plot  
Wiltshire3   ACTH_index  
adrenocorticotropic hormone (ACTH), change index (fluoxetine )
male 0.68 p < 0.0001 0.41 30 Plot  
Wiltshire3   GIRK3_index  
G protein-activated inward rectifier potassium channel 3 (GIRK3 formerly KCNJ9), change index (fluoxetine )
male 0.68 p < 0.0001 0.41 30 Plot  
Wiltshire3   CREB1_fluox  
cyclic AMP-responsive element-binding protein 1 (CREB1 formerly CREB), relative fluorescence intensity (fluoxetine )
male 0.67 p < 0.0001 0.47 30 Plot  
Wiltshire3   GHRL_fluox  
ghrelin (GHRL), relative fluorescence intensity (fluoxetine )
male 0.66 p < 0.0001 0.50 30 Plot  
Wiltshire3   BDNF_index  
brain-derived neurotrophic factor (BDNF), change index (fluoxetine )
male 0.66 p < 0.0001 0.53 30 Plot  
Wiltshire3   TNF_index  
tumor necrosis factor (TNF formerly TNFa), change index (fluoxetine )
male 0.65 p = 0.0001 0.50 30 Plot  
Wiltshire3   NPY_fluox  
neuropeptide Y (NPY), relative fluorescence intensity (fluoxetine )
male 0.64 p = 0.0001 0.50 30 Plot  
Wiltshire3   SLC6A4_index  
sodium-dependent serotonin transporter (SLC6A4 formerly SERT), change index (fluoxetine )
male 0.64 p = 0.0001 0.45 30 Plot  
Wiltshire3   NPY_index  
neuropeptide Y (NPY), change index (fluoxetine )
male 0.63 p = 0.0002 0.52 30 Plot  
Wiltshire3   NGF_index  
nerve growth factor (NGF), change index (fluoxetine )
male 0.63 p = 0.0002 0.50 30 Plot  
Wiltshire3   SLC6A2_fluox  
sodium-dependent noradrenaline transporter (SLC6A2 formerly NET), relative fluorescence intensity (fluoxetine )
male 0.63 p = 0.0002 0.40 30 Plot  
Wiltshire3   GSR_index  
glutathione reductase (GSR), change index (fluoxetine )
male 0.61 p = 0.0004 0.32 30 Plot  
Wiltshire3   APOD_index  
apolipoprotein D (APOD), change index (fluoxetine )
male 0.60 p = 0.0004 0.23 30 Plot  
Wiltshire3   GRIN1_index  
glutamate receptor NMDA1 subunit zeta 1 (GRIN1 formerly NMDA1), change index (fluoxetine )
male 0.60 p = 0.0005 0.45 30 Plot  
Wiltshire3   SST_index  
somatostatin (SST), change index (fluoxetine )
male 0.59 p = 0.0006 0.47 30 Plot  
Wiltshire3   S100B_fluox  
protein S100-B (S100B), relative fluorescence intensity (fluoxetine )
male 0.59 p = 0.0006 0.51 30 Plot  
Wiltshire3   S100B_index  
protein S100-B (S100B), change index (fluoxetine )
male 0.57 p = 0.0009 0.63 30 Plot  
Wiltshire3   PTH_index  
parathyroid hormone (PTH), change index (fluoxetine )
male 0.57 p = 0.0010 0.27 30 Plot  
Wiltshire3   ACTH_fluox  
adrenocorticotropic hormone (ACTH), relative fluorescence intensity (fluoxetine )
male 0.55 p = 0.0016 0.32 30 Plot  
Wiltshire3   SCG5_fluox  
secretogranin V (SCG5 formerly SGNE), relative fluorescence intensity (fluoxetine )
male 0.55 p = 0.0017 0.46 30 Plot  
Wiltshire3   FUT9_cont  
fucosyltransferase 9 (FUT9), relative fluorescence intensity
male –0.55 p = 0.0018 –0.30 30 Plot  
Wiltshire3   GHRL_cont  
ghrelin (GHRL), relative fluorescence intensity
male –0.55 p = 0.0018 –0.49 30 Plot  
Wiltshire3   PTH_cont  
parathyroid hormone (PTH), relative fluorescence intensity
male –0.54 p = 0.0020 –0.34 30 Plot  
Wiltshire3   GIRK3_fluox  
G protein-activated inward rectifier potassium channel 3 (GIRK3 formerly KCNJ9), relative fluorescence intensity (fluoxetine )
male 0.54 p = 0.0022 0.30 30 Plot  
Wiltshire3   SLC6A4_fluox  
sodium-dependent serotonin transporter (SLC6A4 formerly SERT), relative fluorescence intensity (fluoxetine )
male 0.53 p = 0.0024 0.31 30 Plot  
Wiltshire3   BAG1_index  
BAG family molecular chaperone regulator 1 (BAG1), change index (fluoxetine )
male 0.52 p = 0.0032 0.26 30 Plot  
Wiltshire3   GFAP_index  
glial fibrillary acidic protein (GFAP), change index (fluoxetine )
male 0.52 p = 0.0032 0.52 30 Plot  
Wiltshire3   FOS_cont  
proto-oncogene c-Fos (FOS formerly c-fos), relative fluorescence intensity
male –0.51 p = 0.0036 –0.31 30 Plot  
Wiltshire3   GAL_fluox  
galanin (GAL), relative fluorescence intensity (fluoxetine )
male 0.47 p = 0.0091 0.54 30 Plot  
cardiovascular – heart rate
Maurer1   pulse_iso10  
pulse rate (isoproterenol 10mg/kg)
male –0.65 p = 0.0019 –0.65 20 Plot  
endocrine – hormones
Naggert1   LEP_fat18  
leptin (high-fat diet 18wks)
male –0.52 p = 0.0068 –0.47 26 Plot  
liver – lipid homeostasis
Paigen1   free_to_est  
hepatic cholesterol concentration (free to esterified ratio) (high-fat diet 8wks)
male 0.52 p = 0.0078 0.39 25 Plot  
respiratory – breathing pattern
Berndt2   penh_slope  
enhanced pause (Penh), MCh response index (methacholine )
male 0.56 p = 0.0059 0.48 23 Plot  
Berndt2   insp_flow_saline  
inspiratory flow rate (Vt/Ti), saline
male 0.55 p = 0.0070 0.55 23 Plot  
Berndt2   min_vent_saline  
minute ventilation (MV), saline
male 0.53 p = 0.0098 0.55 23 Plot  
 

52 rows

Reciprocals are included in the above list.

Correlations where Pearson r < 0.5 are not retained and will not appear in the above list.

All correlations available through MPD are mathematical correlations provided for exploratory use, and are not necessarily biologically significant. Additional forms of validation are required. Most correlations are based on strain mean data points which have varying degrees of quality, preciseness, and normality of distribution, and this is generally not taken into account in correlation strength metrics.




Contact us
About MPD
Also at JAX
  Units
Changelog
Downloads
  Citing
Funding
Terms of Use